The International Symposium on Regenerative Rehabilitation Scientific Program Committee will be soliciting abstracts that address the principles of regenerative medicine and how rehabilitation interfaces with these state-of-the-art technologies for optimal patient recovery. Topics that will be considered include but are not limited to the following:
- Clinically relevant applications of regenerative medicine combined with rehabilitation protocols in core foundational areas such as musculoskeletal, neuromuscular, cardiopulmonary, and integumentary
- Mechanical stimulation in cellular therapeutics and tissue engineering
- In vitro and in vivo investigations for understanding molecular and cellular responses to biophysical signals
- Implantable sensors to monitor tissue responses
- Integration of pharmacological agents
- Prosthetics and regenerative rehabilitation
- Biomaterials and device interface
- Advances in the biology of tissue regeneration and plasticity and implications for clinical practices
All accepted abstracts will be expected to participate in the poster session, but a select number of abstracts will also be invited to give oral presentations. The meeting will include three formats for presentations:
- Oral Presentations: selected presenters will give 15-minute talks followed by 5 minutes for questions.
- Rapid-Fire Oral Presentations: selected presenters will provide succinct overviews of their research findings in advance of the poster sessions.
- Poster Session: for the 2021 symposium, all posters will be displayed on poster boards in a 4’x4’ format. Presenters will be assigned to a session, during which they will attend their poster, answer questions, and discuss their work.
Each abstract is accompanied by a 100-word synopsis for inclusion in the online program. It should include a brief summary of the problem, methods, results, and conclusions. The synopsis must include text only, without equations or images and be without references or citations to items described in the full abstract. The synopsis text should NOT be duplicated in the actual abstract.
We recommend including the following sections, although we also note that there are often good reasons to deviate from this format. In each section, answer the question listed below (do not repeat the actual question in the body of your abstract).
INTRODUCTION: “Why was this study/research performed? What unsolved problem are you addressing?”
METHODS: “How did you study this problem?”
RESULTS: “Report the data, analyses and/or outcomes”
DISCUSSION: “How do you interpret the results?”
CONCLUSION: “What is the relevance to clinical practice or future research?”
REFERENCES: References should use the suggested style below.
The following word limits will apply:
Title: 125 characters
Synopsis: 100 words
Body of the Abstract: 750 words (references not included)
Summary of Main Findings: ~100 words
Up to 5 figures
Figure Captions: 500 characters per caption
Abstract Content Guidelines
- Content must be restricted to scientific and engineering research and/or related clinical studies. The content may not promote the proprietary interests of any commercial entity. Evident bias in favor of a particular product or company is grounds for rejection.
- All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for the recommendations as indications or contraindications in the care of patients.
- All scientific research referred to, reported or used in support or justification of a patient care recommendation must conform to generally accepted standards of experimental design, data collection and analysis.
- Abstracts previously submitted to AR3T or to another society/journal, but not accepted, may be resubmitted.
- While duplicate material is not permitted, closely related/similar material is acceptable (for example, significant progress on research that was presented at the symposium in a previous year).
Abstract Review Criteria
Innovation/novelty: advancement of knowledge, and/or improvement of capabilities.
Quality: The results should be substantive and not just implied. Where appropriate:
Comprehensive statistical analysis should be applied.
Images and spectra should be of the highest quality.
All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
Impact: The method or data in the abstract should aim to advance or change the field in significant ways. Incremental changes are less likely to be accepted for presentation.
Bias: Evident bias in favor of a particular product or company is grounds for rejection. (Reference to the use of a particular company’s products or equipment does not represent bias. Non-data-driven statements of superiority, however, would be considered biased.)
Duplication of Content: Multiple submissions of the same or nearly the same abstract is grounds for rejection of all submitted abstracts.
All question regarding abstract submission should be directed to Katy Wharton at email@example.com.